Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis.
|
Circulation
|
2003
|
6.62
|
2
|
High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: a population-based cohort study.
|
Arthritis Rheum
|
2008
|
2.14
|
3
|
Arterial stiffness in chronic inflammatory diseases.
|
Hypertension
|
2005
|
1.53
|
4
|
How much of the increased incidence of heart failure in rheumatoid arthritis is attributable to traditional cardiovascular risk factors and ischemic heart disease?
|
Arthritis Rheum
|
2005
|
1.49
|
5
|
Overview of epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis.
|
Am J Manag Care
|
2012
|
1.37
|
6
|
Emerging cell and cytokine targets in rheumatoid arthritis.
|
Nat Rev Rheumatol
|
2013
|
1.32
|
7
|
Role of inflammation in the pathogenesis of arterial stiffness.
|
Yonsei Med J
|
2012
|
1.21
|
8
|
Arterial stiffness and central blood pressure, as determined by pulse wave analysis, in rheumatoid arthritis.
|
Ann Rheum Dis
|
2003
|
1.09
|
9
|
Arterial stiffness and cumulative inflammatory burden in rheumatoid arthritis: a dose-response relationship independent of established cardiovascular risk factors.
|
Rheumatology (Oxford)
|
2009
|
1.00
|
10
|
Cardiovascular risk in rheumatoid arthritis: pathogenesis, diagnosis, and management.
|
J Clin Rheumatol
|
2012
|
0.91
|
11
|
Increased arterial stiffness and indication of endothelial dysfunction in long-standing rheumatoid arthritis.
|
Scand J Rheumatol
|
2008
|
0.90
|
12
|
Patient-reported outcomes as end points in clinical trials in rheumatoid arthritis.
|
RMD Open
|
2015
|
0.90
|
13
|
Cardiovascular disease risk in rheumatoid arthritis: progress, debate, and opportunity.
|
Arthritis Care Res (Hoboken)
|
2011
|
0.87
|
14
|
Serum levels of anticyclic citrullinated peptide antibodies, interleukin-6, tumor necrosis factor-α, and C-reactive protein are associated with increased carotid intima-media thickness: a cross-sectional analysis of a cohort of rheumatoid arthritis patients without cardiovascular risk factors.
|
Biomed Res Int
|
2015
|
0.78
|
15
|
Disease duration of rheumatoid arthritis is a predictor of vascular stiffness: a cross-sectional study in patients without known cardiovascular comorbidities: A STROBE-compliant article.
|
Medicine (Baltimore)
|
2017
|
0.75
|